This Peer Exchange® centers on navigating the complexities of drug pricing, market access, and reimbursement through the balance of regulatory, payer, and patient perspectives using modern innovative approaches, partnerships, and technologies.
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
How Pharma is Adjusting Strategies for Changing Dynamics at FDA
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5